Cardiovascular Research - Matrix and Inflammation in Atherosclerosis
1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
(
- Contribution to journal › Article
-
Mark
Intermediate Monocytes and High Levels of Chemokine CCL3 Are Associated With Increased Risk of Atrial Fibrillation in the General Population
2025) In Circulation: Arrhythmia and Electrophysiology(
- Contribution to journal › Article
-
Mark
The interaction of human serum components with model membranes containing phospholipids and lipopolysaccharides
(
- Contribution to journal › Article
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
-
Mark
Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis
(
- Contribution to journal › Article
-
Mark
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
(
- Contribution to journal › Article
- 2023
-
Mark
Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort
(
- Contribution to journal › Article
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
(
- Contribution to journal › Article
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article